8EP5

Solution NMR structure of a computationally designed mastoparan-like peptide, mastoparan-R1

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H TOCSY	1.5 mM Mastoparan-R1, 75 mM [U-98% 2H] SDS-d25, 0.05 % [U-98% 2H] DSS-d6	90% H2O/10% D2O	acid	4.0	1 atm	298	Bruker AVANCE III 500
2	2D 1H-1H NOESY	1.5 mM Mastoparan-R1, 75 mM [U-98% 2H] SDS-d25, 0.05 % [U-98% 2H] DSS-d6	90% H2O/10% D2O	acid	4.0	1 atm	298	Bruker AVANCE III 500
3	2D 1H-13C HSQC	1.5 mM Mastoparan-R1, 75 mM [U-98% 2H] SDS-d25, 0.05 % [U-98% 2H] DSS-d6	90% H2O/10% D2O	acid	4.0	1 atm	298	Bruker AVANCE III 500

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	500

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNmr Analysis	2.5.2	CCPN
2	structure calculation	ARIA	2.3.2	Linge, O'Donoghue and Nilges
3	processing	TopSpin		Bruker Biospin
4	peak picking	CcpNmr Analysis		CCPN
5	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.